Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 2, 2026
Sale
Shares
12,063
Price
$44.20
Total Value
$533.18K
Shares Held After
89,261
% of Holdings
11.9%

Tempus AI, Inc. (TEM)

Rogers James William — Chief Financial Officer
Mar 2, 2026
Sale
Shares
11,414
Price
$50.69
Total Value
$578.58K
Shares Held After
127,248
% of Holdings
8.2%
Shares
156,235
Price
$8.17
Total Value
$1.28M
Shares Held After
2,704,496
% of Holdings
5.5%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
15,000
Price
$35.36
Total Value
$530.40K
Shares Held After
1,262
% of Holdings
92.2%

Vericel Corp (VCEL)

Flynn Sean C. — Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,421
Price
$34.75
Total Value
$223.13K
Shares Held After
1,262
% of Holdings
83.6%
Mar 2, 2026
Sale
Shares
100
Price
$10.83
Total Value
$1.08K
Shares Held After
21,906
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,911
Price
$1.43
Total Value
$4.16K
Shares Held After
365,734
% of Holdings
0.8%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
1,861
Price
$1.43
Total Value
$2.66K
Shares Held After
368,645
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,125
Price
$1.43
Total Value
$3.04K
Shares Held After
370,506
% of Holdings
0.6%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Mar 2, 2026
Sale
Shares
835
Price
$1.43
Total Value
$1.19K
Shares Held After
372,631
% of Holdings
0.2%

Vanda Pharmaceuticals Inc. (VNDA)

Birznieks Gunther — SVP, Business Development
Mar 2, 2026
Sale
Shares
42,431
Price
$8.27
Total Value
$350.73K
Shares Held After
494,197
% of Holdings
7.9%
Mar 2, 2026
Sale
Shares
6,097
Price
$8.30
Total Value
$50.60K
Shares Held After
89,790
% of Holdings
6.4%
Mar 2, 2026
Sale
Shares
583
Price
$47.01
Total Value
$27.41K
Shares Held After
45,761
% of Holdings
1.3%
Mar 2, 2026
Sale
Shares
1,292
Price
$46.67
Total Value
$60.30K
Shares Held After
46,344
% of Holdings
2.7%
Mar 2, 2026
Sale
Shares
10,429
Price
$47.01
Total Value
$490.31K
Shares Held After
98,748
% of Holdings
9.6%
Mar 2, 2026
Sale
Shares
22,487
Price
$46.67
Total Value
$1.05M
Shares Held After
109,177
% of Holdings
17.1%

Oscar Health, Inc. (OSCR)

McAnaney Adam — Chief Legal Officer
Mar 2, 2026
Sale
Shares
18,710
Price
$13.39
Total Value
$250.53K
Shares Held After
227,955
% of Holdings
7.6%
Mar 2, 2026
Sale
Shares
197,855
Price
$13.29
Total Value
$2.63M
Shares Held After
1,356,646
% of Holdings
12.7%

Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Mar 2, 2026
Sale
Shares
2,594
Price
$3.31
Total Value
$8.59K
Shares Held After
28,100
% of Holdings
8.5%

Whitehawk Therapeutics, Inc. (WHWK)

BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Mar 2, 2026
Sale
Shares
1,834
Price
$3.31
Total Value
$6.07K
Shares Held After
206,019
% of Holdings
0.9%
Mar 2, 2026
Sale
Shares
5,100
Price
$3.31
Total Value
$16.88K
Shares Held After
44,579
% of Holdings
10.3%

Alector, Inc. (ALEC)

Rosenthal Arnon — Director
Mar 2, 2026
Sale
Shares
81,864
Price
$2.12
Total Value
$173.82K
Shares Held After
2,338,176
% of Holdings
3.4%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
Mar 2, 2026
Sale
Shares
3,119
Price
$22.54
Total Value
$70.30K
Shares Held After
86,669
% of Holdings
3.5%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
Mar 2, 2026
Sale
Shares
5,290
Price
$22.80
Total Value
$120.61K
Shares Held After
89,788
% of Holdings
5.6%

Schrödinger, Inc. (SDGR)

Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Mar 2, 2026
Sale
Shares
2,206
Price
$11.99
Total Value
$26.45K
Shares Held After
71,322
% of Holdings
3.0%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
2,600
Price
$235.26
Total Value
$611.68K
Shares Held After
4,619
% of Holdings
36.0%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
10,291
Price
$234.66
Total Value
$2.41M
Shares Held After
7,219
% of Holdings
58.8%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Mar 2, 2026
Sale
Shares
5,777
Price
$233.51
Total Value
$1.35M
Shares Held After
17,510
% of Holdings
24.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,163
Price
$28.96
Total Value
$33.68K
Shares Held After
44,086
% of Holdings
2.6%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
41,329
% of Holdings
2.8%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
38,516
% of Holdings
4.2%

AGIOS PHARMACEUTICALS, INC. (AGIO)

Burns James William — Chief Legal Officer
Mar 2, 2026
Sale
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
34,531
% of Holdings
3.3%

agilon health, inc. (AGL)

Shaker Benjamin — Chief Markets Officer
Mar 2, 2026
Purchase
Shares
500,000
Price
$0.60
Total Value
$301.05K
Shares Held After
1,367,674
% of Holdings
36.6%

Liquidia Corp (LQDA)

Moomaw Scott — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
827
Price
$30.58
Total Value
$25.29K
Shares Held After
188,954
% of Holdings
0.4%
Mar 2, 2026
Purchase
Shares
7,534
Price
$2.90
Total Value
$21.85K
Shares Held After
8,292
% of Holdings
90.9%
Mar 2, 2026
Sale
Shares
5,000
Price
$61.21
Total Value
$306.05K
Shares Held After
17,933
% of Holdings
21.8%

Claritev Corp (CTEV)

O'Neil Tara — SVP, General Counsel
Mar 2, 2026
Purchase
Shares
750
Price
$12.99
Total Value
$9.74K
Shares Held After
27,199
% of Holdings
2.8%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
886
Price
$61.62
Total Value
$54.60K
Shares Held After
50,440
% of Holdings
1.7%
Mar 2, 2026
Sale
Shares
1,183
Price
$427.21
Total Value
$505.39K
Shares Held After
9,257
% of Holdings
11.3%
Mar 2, 2026
Sale
Shares
443,707
Price
$33.25
Total Value
$14.75M
Shares Held After
174,144
% of Holdings
71.8%

Edwards Lifesciences Corp (EW)

BOBO DONALD E JR — CVP,Strategy/Corp Development
Mar 2, 2026
Sale
Shares
11,340
Price
$85.93
Total Value
$974.43K
Shares Held After
21,266
% of Holdings
34.8%

Monte Rosa Therapeutics, Inc. (GLUE)

Dunn Edmund — Principal Accounting Officer
Mar 2, 2026
Sale
Shares
536
Price
$17.50
Total Value
$9.38K
Shares Held After
22,693
% of Holdings
2.3%
Mar 2, 2026
Sale
Shares
55,930
Price
$107.81
Total Value
$6.03M
Shares Held After
1,476,500
% of Holdings
3.6%

TransMedics Group, Inc. (TMDX)

Hernandez Gerardo — Chief Financial Officer
Mar 2, 2026
Sale
Shares
375
Price
$139.12
Total Value
$52.17K
Shares Held After
14,689
% of Holdings
2.5%

TransMedics Group, Inc. (TMDX)

Ranganath Anil P. — Senior Vice President, General Counsel and Secretary
Mar 2, 2026
Sale
Shares
864
Price
$139.12
Total Value
$120.20K
Shares Held After
13,091
% of Holdings
6.2%

TransMedics Group, Inc. (TMDX)

Corcoran Nicholas — SVP of Supply Chain and Operations
Mar 2, 2026
Sale
Shares
2,966
Price
$139.12
Total Value
$412.63K
Shares Held After
29,831
% of Holdings
9.0%

Alkermes plc. (ALKS)

Parisi Samuel Joseph — VP, Finance (Interim PAO)
Mar 2, 2026
Sale
Shares
6,890
Price
$29.29
Total Value
$201.81K
Shares Held After
7,717
% of Holdings
47.2%

Alkermes plc. (ALKS)

Nichols Christian Todd — SVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
6,000
Price
$30.00
Total Value
$180.00K
Shares Held After
109,769
% of Holdings
5.2%

Adaptive Biotechnologies Corp (ADPT)

ROBINS HARLAN S — Chief Scientific Officer
Mar 2, 2026
Sale
Shares
10,000
Price
$15.72
Total Value
$157.20K
Shares Held After
1,169,524
% of Holdings
0.8%
Mar 2, 2026
Sale
Shares
22,500
Price
$14.35
Total Value
$322.84K
Shares Held After
998,680
% of Holdings
2.2%
Version: v26.3.33